Danavorexton
id:
danavorexton-163-18297214
title:
Danavorexton
text:
Danavorexton is a selective orexin 2 receptor agonist. It is a small-molecule compound and is administered intravenously. The compound was found to dose-dependently produce wakefulness to a similar degree as modafinil in a phase 1 clinical trial. As of March 2021, danavorexton is under development for the treatment of narcolepsy, idiopathic hypersomnia, and sleep apnea. It is related to another orexin receptor agonist, firazorexton (TAK-994), the development of which was discontinued for safety
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Danavorexton
date created:
2021-03-07T02:58:38Z
date modified:
2024-08-28T16:44:07Z
main entity:
{"identifier":"Q105802855","url":"https://www.wikidata.org/entity/Q105802855"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5c/Danavorexton_Structure.svg","width":512,"height":341}
fields total:
13
integrity:
16